Sequential evaluation of hepatic functional reserve by ^99mTechnetium-galactosyl human serum albumin scinitigraphy after proton beam therapy: a report of three cases and a review of the literatures

References

• Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429–33
   PubMedGoogle Scholar
• Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 2842–7
   PubMed Web of Science ®Google Scholar
• Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59–71
   PubMed Web of Science ®Google Scholar
• Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004; 11: 84–91
   PubMedGoogle Scholar
• Suit H, Goldberg S, Niemierko A, Trofimov A, Adams J, Paganetti H, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003; 42: 800–8
   PubMed Web of Science ®Google Scholar
• Brahme A. Recent advances in light ion radiation therapy. Int J Radiat Oncol Biol Phys 2004; 58: 603–16
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed. Acta Oncol 2005; 44: 825–8
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ask A, Bjelkengren G, Bjork-Eriksson T, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005; 44: 836–49
   PubMed Web of Science ®Google Scholar
• Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, et al. Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin Cancer Res 2005; 11: 3799–805
   PubMed Web of Science ®Google Scholar
• Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2005; 104: 794–801
   PubMed Web of Science ®Google Scholar
• Nemoto K, Tokuue K, Onishi K, Mizumoto M, Hashimoto T, Igaki H, et al. Proton beam therapy for large hepatocellular carcinoma [in Japanese]. J Jpn Soc Ther Radiol Oncol 2004; 16: 177–82
   Google Scholar
• Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005; 23: 1839–46
   PubMed Web of Science ®Google Scholar
• Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 2004; 127(5 Suppl 1)S189–S193
   Web of Science ®Google Scholar
• Kudo M, Todo A, Ikekubo K, Hino M, Yonekura Y, Yamamoto K, et al. Functional hepatic imaging with receptor-binding radiopharmaceutical: Clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 1991; 26: 734–41
   PubMedGoogle Scholar
• Ahmadi T, Itai Y, Onaya H, Yoshioka H, Okumura T, Akine Y. CT evaluation of hepatic injury following proton beam irradiation: Appearance, enhancement, and 3D size reduction pattern. J Comput Assist Tomogr 1999; 23: 655–63
   PubMedGoogle Scholar
• Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage. Am J Gastroenterol 1992; 87: 865–70
   PubMedGoogle Scholar
• Wu J, Ishikawa N, Takeda T, Sato M, Fukunaga K, Todoroki T, et al. Evaluation of reserved hepatic function in patients with hepatobiliary tumor by 99mTc-GSA: Effect of hyperbilirubinemia and usefulness of regional reserved hepatic functional imaging. Kaku Igaku (Jpn J Nucl Med) 1996; 33: 161–8
   PubMedGoogle Scholar
• Toyama H, Ito K, Komori Y, Sugioka A, Shibata K, Komai S, et al. Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agent. Kaku Igaku (Jpn J Nucl Med) 1995; 32: 323–9
   PubMedGoogle Scholar
• Kondo M. Usefulness of 99mTc-GSA scintigraphy for estimation of residual hepatic functions and postoperative changes of HH15 and LHL15. Kaku Igaku (Jpn J Nucl Med) 2001; 38: 191–200
   PubMedGoogle Scholar
• Wood AJ, Villeneuve JP, Branch RA, Rogers LW, Shand DG. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. Gastroenterology 1979; 76: 1358–62
   PubMed Web of Science ®Google Scholar
• Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987; 206: 30–9
   PubMed Web of Science ®Google Scholar
• Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993; 18: 79–85
   PubMed Web of Science ®Google Scholar
• Efimova EA, Glanemann M, Nussler AK, Schumacher G, Settmacher U, Jonas S, et al. Changes in serum levels of growth factors in healthy individuals after living related liver donation. Transplant Proc 2005; 37: 1074–5
   PubMedGoogle Scholar
• de Jong KP, von Geusau BA, Rottier CA, Bijzet J, Limburg PC, de Vries EG, et al. Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 2001; 34: 422–7
   PubMedGoogle Scholar
• Yamazaki H, Matsumoto K, Inoue T, Nose T, Murayama S, Teshima T, et al. Induction of hepatocyte growth factor in the liver, kidney and lung following total body irradiation in rat. Cytokine 1996; 8: 927–32
   PubMedGoogle Scholar
• Kouda K, Ha-Kawa SK, Tanaka Y. Increased technetium-99m-GSA uptake per hepatocyte in rats with administration of dimethylnitrosamine or hepatocyte growth factor. J Nucl Med 1998; 39: 1463–7
   PubMedGoogle Scholar
• Fukui A, Murase K, Tsuda T, Fujii T, Ikezoe J. Assessment of liver function in chronic liver diseases and regional function of irradiated liver by means of 99mTc-galactosyl-human serum albumin liver scintigraphy and quantitative spectral analysis. Ann Nucl Med 2000; 14: 467–76
   PubMedGoogle Scholar